Back to KROS
RBF Capital, LLC KROS Position History
Keros Therapeutics, Inc. • Healthcare
Quarters held
6
Latest value
$716K
Q3 2026
Peak value
$1.7M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $1.7M |
| Q4 2025 | $1.7M |
| Q1 2026 | $693K |
| Q1 2026 | $693K |
| Q2 2026 | $672K |
| Q3 2026 | $716K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $716K | 62.8K | — | — |
| Q2 2026 | $672K | 62.8K | — | — |
| Q1 2026 | $693K | 62.8K | — | — |
| Q1 2026 | $693K | 62.8K | — | — |
| Q4 2025 | $1.7M | 81.7K | — | — |
| Q4 2025 | $1.7M | 81.7K | — | — |